NCT00713674 (SJMRSA) is a NA clinical trial of Theraworx in Methicillin-Resistant Staphylococcus Aureus, sponsored by Mercy Research.

Who is sponsoring NCT00713674?

NCT00713674 is sponsored by Mercy Research.

What drugs are being tested in NCT00713674?

Interventions in NCT00713674: Theraworx, mupirocin antibiotic ointment.

What condition does NCT00713674 study?

NCT00713674 studies Methicillin-Resistant Staphylococcus Aureus.

Is NCT00713674 still recruiting?

NCT00713674 is currently withdrawn. Last updated 21 March 2017.

Last reviewed 2017-03-21 · How we verify

NCT00713674: SJMRSA

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Comparison of Decolonization of MRSA Using Theraworx

Withdrawn NA Last updated 21 March 2017

What this trial tests

NA trial testing Theraworx in Methicillin-Resistant Staphylococcus Aureus. Withdrawn.

Timeline

1 March 2008

Primary endpoint
1 February 2009

1 February 2009

Quick facts

Lead sponsor	Mercy Research
Phase	NA
Status	Withdrawn
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Start date	1 March 2008
Primary completion	1 February 2009
Estimated completion	1 February 2009

Drugs / interventions tested

Theraworx — full drug profile →
mupirocin antibiotic ointment — full drug profile →

Conditions studied

Methicillin-Resistant Staphylococcus Aureus — all drugs for Methicillin-Resistant Staphylococcus Aureus →

Sponsor

Mercy Research — full company profile →

Who can join

18 and older, any sex, with Methicillin-Resistant Staphylococcus Aureus. Healthy volunteers can join.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Evidence of decolonization confirmed by intranasal culture
Time frame: Up to 14 days post treatment (+/- 1-2 days)

Sponsor's own description

The purpose of this study is to examine treatment method of Methicillin-resistant Staphylococcus aureus (MRSA) decolonization in patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Theraworx

Trials testing the same drug.

NCT03770091 — Impact of TheraWorx Foam on Symptom Relief in Thumb Arthritis · Phase 3 · completed
NCT03159260 — Effect of Theraworx/[pH]Uel on Night-time Leg Cramps and Spasm Symptoms · NA · completed

Other Mercy Research trials

Trials by the same sponsor.

NCT04202718 — VitalConnect VitalPatch ECG Interpretation/Arrhythmia Detection · NA · withdrawn
NCT04137770 — Application of the ICE-T Postoperative Multimodal Pain Regimen to Laparoscopic Hysterectomy · NA · terminated
NCT03956082 — Ultravision™ System to Facilitate Low Impact Laparoscopic Surgery for Endometriosis · NA · completed
NCT03634306 — Ultravision Visual Clearing System in Laparoscopic Hysterectomy and Myomectomy · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT00713674 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Mercy Research
Last refreshed: 21 March 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00713674.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing